Literature DB >> 9833215

A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathologic correlation of 90 cases.

H Rassael1, L D Thompson, C S Heffess.   

Abstract

Microscopic papillary carcinoma of the thyroid gland (MPC) measuring < or = 1.0 cm in diameter has a generally benign outcome, but is often overtreated with additional surgery. Ninety cases of MPC and 77 cases of nonmicroscopic papillary carcinoma of the thyroid gland (non-MPC) from 1970 to 1980 were retrieved from the Endocrine Registry of the Armed Forces Institute of Pathology (AFIP), Washington, D.C. Histologic features and patient follow-up were analyzed. Twenty-one patients with MPC had multifocal disease within the affected thyroid lobe, while a further 15 had either bilateral or intraglandular spread. Four of 10 patients who had additional surgery were found to have additional foci of tumor. Fourteen patients with lymph node metastases at initial surgery had no subsequent nodal metastases. All patients were either alive without disease or had died of unrelated causes after an average follow-up period of 17.3 years. Of the 77 non-MPC patients, 13 developed lymph node metastases or local recurrences, and one died of metastatic disease. Sixty-four of these patients were alive without evidence of disease after an average follow-up of 22 years. Present findings show that while MPC may present with perithyroidal lymph node metastases (15.56%), patients do not develop clinical tumors in the remaining thyroid tissue. Our experience indicates that close clinical follow-up without additional surgery is the preferable management for patients with MPC.

Entities:  

Mesh:

Year:  1998        PMID: 9833215     DOI: 10.1007/s004050050100

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  7 in total

1.  A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.

Authors:  Leo A Niemeier; Haruko Kuffner Akatsu; Chi Song; Sally E Carty; Steven P Hodak; Linwah Yip; Robert L Ferris; George C Tseng; Raja R Seethala; Shane O Lebeau; Michael T Stang; Christopher Coyne; Jonas T Johnson; Andrew F Stewart; Yuri E Nikiforov
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

2.  An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hiroyuki Inoue; Mitsuhiro Fukushima; Minoru Kihara; Takuya Higashiyama; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

3.  Papillary microcarcinoma of the thyroid: how should it be treated?

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma.

Authors:  Yasuhiro Ito; Kaoru Kobayashi; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-08       Impact factor: 3.352

5.  Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Papillary microcarcinoma.

Authors:  Shiro Noguchi; Hiroto Yamashita; Shinya Uchino; Shin Watanabe
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

7.  The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.

Authors:  Sun Yi Choi; Heonsoo Park; Myung Koo Kang; Dong Kun Lee; Kang Dae Lee; Hyoung Shin Lee; Sung Won Kim; Eun Nam Lee; Jong Chul Hong
Journal:  World J Surg Oncol       Date:  2013-11-14       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.